C
Cue Biopharma, Inc. (CUE)
NCM – Real vaqt narxi. Valyuta: USD
25.39
-0.15 (-0.59%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
25.09
-0.30 (-1.18%)
Bozordan keyin: Jun 26, 2026, 5:11 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
25.39
-0.15 (-0.59%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
25.09
-0.30 (-1.18%)
Bozordan keyin: Jun 26, 2026, 5:11 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $16.4M umumiy qarzdan $3.4M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $26.4M jami joriy majburiyatlardan $7.4M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.2) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-1,340.8x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$11.1M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 3.57 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 3.57 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.16 | 0.30 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.11 | 1.04 | 8.0 | |
| Foiz to‘lov qoplami | -1340.75 | -16.91 | 1.0 | |
| O‘rtacha ball | 7.6 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 1M | 5M | 9M | 27M | 33M |
| Yalpi foyda | -561K | 2M | 7M | 27M | 32M |
| Operatsion daromad | -54M | -52M | -42M | -27M | -20M |
| Sof foyda | -53M | -51M | -41M | -27M | -20M |
| EBITDA | -52M | -49M | -39M | -26M | -19M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 1.56 | 37.41 | 6.5 |
| Keyingi chorak | -2.28 | 9.05 | 3.5 |
| Joriy yil | -53.4 | 20.95 | 5.5 |
| Keyingi yil | -92.19 | -42.32 | 1.0 |
| O‘rtacha ball | 4.1 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -74.08 | -426.68 | -459.99 | -928.15 | 1.0 |
| Yil/Yil | 1250.59 | 57.75 | 78.82 | -32.93 | 7.8 |
| 3 yil o‘rtacha | 201.93 | 19.58 | 40.58 | 17.88 | 9.5 |
| 5 yil o‘rtacha | 177.56 | 8.02 | 25.14 | 5.59 | 7.8 |
| O‘rtacha ball | 6.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |